IMA · ImageneBio, Inc. · Documents

$4.25 +0.23 (+5.60%)

Market Cap

$45.63M

11.35M

Volume · Nov 4 104 Avg daily vol (3M) 13.65K

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

2024

Nov 7

Quarterly report 10-Q FY2024 Q3, ended Sep 30

Quarterly report for FY2024 Q3

Net loss $10.23M Diluted EPS -$0.21

Aug 8

Quarterly report 10-Q FY2024 Q2, ended Jun 30

Quarterly report for FY2024 Q2

Net loss $13.73M Diluted EPS -$0.28

Jul 12

Current report 8-K Events of Jul 8

Director or officer change, or executive pay

Jun 10

Current report 8-K Events of Jun 7

Shareholder vote results

May 28

Current report 8-K Events of May 23

Exit or restructuring costs, Regulation FD disclosure, Other events

May 13

Quarterly report 10-Q FY2024 Q1, ended Mar 31

Quarterly report for FY2024 Q1

Net loss $16.15M Diluted EPS -$0.33

Apr 26

Proxy statement DEF 14A Meeting Jun 7, 2024

Proxy statement

Apr 26

Annual report to holders ARS

Annual report to holders

Apr 26

Proxy statement DEFA14A

Proxy statement

Mar 12

Annual report 10-K FY2023, ended Dec 31

Annual report for FY2023

Revenue $9.16M ▼ 41.3% Net loss $68.17M Diluted EPS -$1.63

Feb 21

Current report 8-K Events of Feb 20

Director or officer change, or executive pay, Regulation FD disclosure

Jan 18

Current report 8-K Events of Jan 17

Financial results, Exit or restructuring costs, Regulation FD disclosure, Other events

2023

Nov 9

Current report 8-K

Financial results, Other events

Nov 9

Quarterly report 10-Q FY2023 Q3, ended Sep 30

Quarterly report for FY2023 Q3

Revenue $1.19M ▼ 81.5% Net loss $17.34M Diluted EPS -$0.40

Oct 11

Current report 8-K

Shareholder vote results

Sep 25

Proxy statement DEF 14A Meeting Oct 11, 2023

Proxy statement

Sep 15

Proxy statement PRE 14A

Proxy statement

Aug 18

Registration statement S-3

Registration statement

Aug 10

Quarterly report 10-Q FY2023 Q2, ended Jun 30

Quarterly report for FY2023 Q2

Revenue $2M ▲ 424.6% Net loss $17.12M Diluted EPS -$0.44

Aug 7

Current report 8-K Events of Aug 4

Entered into a material agreement, Completed an acquisition or sale of assets, Unregistered sale of equity, Charter or bylaw amendment, or fiscal year change, Regulation FD disclosure

Jun 30

Current report 8-K

Delisting notice or listing transfer

Jun 9

Current report 8-K

Shareholder vote results

May 15

Current report 8-K

Entered into a material agreement, Regulation FD disclosure, Other events

May 15

Quarterly report 10-Q FY2023 Q1, ended Mar 31

Quarterly report for FY2023 Q1

Revenue $5.31M ▲ 57.0% Net loss $14.22M Diluted EPS -$0.39

Apr 28

Proxy statement DEF 14A Meeting Jun 9, 2023

Proxy statement

Apr 28

Annual report to holders ARS

Annual report to holders

Apr 28

Proxy statement DEFA14A

Proxy statement

Apr 17

Current report 8-K

Regulation FD disclosure, Other events

Mar 14

Annual report 10-K FY2022, ended Dec 31

Annual report for FY2022

Revenue $15.62M ▼ 49.6% Net loss $68.77M Diluted EPS -$1.90

2022

Dec 19

Current report 8-K Events of Dec 14

Director or officer change, or executive pay

Nov 28

Current report 8-K

Regulation FD disclosure, Other events

Nov 10

Current report 8-K

Regulation FD disclosure, Other events

Nov 7

Quarterly report 10-Q FY2022 Q3, ended Sep 30

Quarterly report for FY2022 Q3

Revenue $6.4M ▲ 70.9% Net loss $17.34M Diluted EPS -$0.48

Aug 11

Quarterly report 10-Q FY2022 Q2, ended Jun 30

Quarterly report for FY2022 Q2

Revenue $382K ▼ 89.2% Net loss $20.49M Diluted EPS -$0.57

Jun 10

Current report 8-K Events of Jun 9

Shareholder vote results

May 12

Quarterly report 10-Q FY2022 Q1, ended Mar 31

Quarterly report for FY2022 Q1

Revenue $3.38M ▼ 2.6% Net loss $16.84M

Apr 27

Proxy statement DEF 14A Meeting Jun 9, 2022

Proxy statement

Apr 27

Registration statement S-3

Registration statement

Apr 27

Proxy statement DEFA14A

Proxy statement

Apr 13

Current report 8-K

Director or officer change, or executive pay

Apr 6

Current report 8-K

Other events

Mar 17

Annual report 10-K FY2021, ended Dec 31

Annual report for FY2021

Revenue $30.99M ▲ 237.0% Net loss $34.12M

Feb 24

Current report 8-K Events of Feb 18

Director or officer change, or executive pay

Jan 28

Current report 8-K

Director or officer change, or executive pay

Jan 26

Current report 8-K Events of Jan 21

Director or officer change, or executive pay

2021

Nov 10

Current report 8-K

Regulation FD disclosure

Nov 10

Quarterly report 10-Q FY2021 Q3, ended Sep 30

Quarterly report for FY2021 Q3

Revenue $3.75M ▲ 32.4% Net loss $14.52M

Aug 12

Current report 8-K

Financial results

Aug 12

Quarterly report 10-Q FY2021 Q2, ended Jun 30

Quarterly report for FY2021 Q2

Revenue $3.55M ▲ 15.5% Net loss $12.68M

May 13

Current report 8-K

Financial results

Showing 51–100 of 105 documents

Key facts CIK 1835579 CUSIP 45175G207 13F (30d) 1 filings 1 filers Visit website Investor relations